Vantage’s Fund II Provides Mezzanine Funding to Austell Laboratories (Sub-Saharan Africa)
Source: Vantage Capital
Mezzanine-focused private investment fund manager Vantage Capital has provided mezzanine financing to South Africa-based Austell Laboratories, a 100 percent black-owned pharmaceutical company. The transaction was structured through Vantage's Fund II. Austell intends to use the financing to fund its working capital needs and to expand its range of products. Financial details of the transaction were not disclosed.